EU Authorized Representative for Aesthetic Laser and IPL Manufacturers: Annex XVI, Regulation (EU) 2022/2347 and the Mandate
Cosmetic lasers and intense pulsed light equipment have no medical purpose, but Article 1(2) of Regulation (EU) 2017/745 brings them under the MDR through point 5 of Annex XVI. Commission Implementing Regulation (EU) 2022/2347 reclassifies them as class IIa for hair removal only and class IIb for any skin treatment, so a notified body is involved. A manufacturer outside the EU must designate a sole authorized representative under Article 11(1).
Why a product without a medical purpose is regulated under the MDR
Hair removal lasers, IPL devices and skin resurfacing or tattoo removal lasers sold for cosmetic use have no intended medical purpose. The MDR still applies to them through Article 1(2):
"This Regulation shall also apply, as from the date of application of common specifications adopted pursuant to Article 9, to the groups of products without an intended medical purpose that are listed in Annex XVI, taking into account the state of the art, and in particular existing harmonised standards for analogous devices with a medical purpose, based on similar technology."
Source: Regulation (EU) 2017/745, Article 1(2)
The relevant entry in Annex XVI is point 5:
"High intensity electromagnetic radiation (e.g. infra-red, visible light and ultra-violet) emitting equipment intended for use on the human body, including coherent and non-coherent sources, monochromatic and broad spectrum, such as lasers and intense pulsed light equipment, for skin resurfacing, tattoo or hair removal or other skin treatment."
Source: Regulation (EU) 2017/745, Annex XVI, point 5
The common specifications that trigger application were adopted by Commission Implementing Regulation (EU) 2022/2346; its Article 3(2) states: "It shall apply from 22 June 2023." Its Annex VI covers lasers and IPL:
"This Annex applies to high intensity electromagnetic radiation (for example infra-red, visible light and ultra-violet) emitting equipment intended for use on the human body, including coherent and non-coherent sources, monochromatic and broad spectrum, such as lasers and intense pulsed light equipment, for skin resurfacing, tattoo or hair removal or other skin treatment, listed in Section 5 of Annex XVI to Regulation (EU) 2017/745."
Source: Commission Implementing Regulation (EU) 2022/2346, Annex VI, Section 1
Products that have both a cosmetic and a medical purpose carry both sets of requirements under Article 1(3). See also our note on Annex XVI products without a medical purpose.
Classification: Rule 13 displaced by Regulation (EU) 2022/2347
MDCG 2021-24 directs Annex XVI products to the ordinary rules of Annex VIII, read with the implementing acts. Rules 9 and 10 refer to a therapeutic or diagnostic purpose, so on their own they could not reach a cosmetic laser; recital 1 of Commission Implementing Regulation (EU) 2022/2347 records that such products would fall to class I under Rule 13. Article 1 of that regulation reclassifies the group by derogation from Rule 13:
"By way of derogation from Section 6.5 of Annex VIII to Regulation (EU) 2017/745, the following groups of active products without an intended medical purpose listed in Annex XVI to that Regulation are reclassified as follows:"
Source: Commission Implementing Regulation (EU) 2022/2347, Article 1
"high intensity electromagnetic radiation emitting equipment as referred to in Section 5 of Annex XVI to Regulation (EU) 2017/745 that is intended for the use on the human body for skin treatment is reclassified as class IIb, unless it is intended for hair removal only in which case it is reclassified as class IIa;"
Source: Commission Implementing Regulation (EU) 2022/2347, Article 1(a)
The class therefore depends on one fact: the intended use stated by the manufacturer. Equipment intended for hair removal only is class IIa. Equipment intended for any skin treatment, which under Annex VI of Regulation (EU) 2022/2346 includes skin resurfacing, skin rejuvenation, tattoo removal, removal of permanent make-up and the non-medical treatment of pigmented areas and scars, is class IIb. A device sold for hair removal and for skin rejuvenation is class IIb, because Section 3.5 of Annex VIII applies the stricter sub-rule.
Equipment that uses the same technologies to reduce adipose tissue is a different Annex XVI group, point 4, which Article 1(b) of the same regulation reclassifies as class IIb.
Classification table
| Product variant | Class | Rule | Notified body |
|---|---|---|---|
| Laser or IPL device intended for hair removal only, no medical purpose | IIa | Annex XVI point 5; Regulation (EU) 2022/2347, Article 1(a) | Yes |
| Laser or IPL device for skin resurfacing, rejuvenation, tattoo or permanent make-up removal, no medical purpose | IIb | Annex XVI point 5; Regulation (EU) 2022/2347, Article 1(a) | Yes |
| Laser, radiofrequency, ultrasound or cryolipolysis equipment to reduce adipose tissue, no medical purpose | IIb | Annex XVI point 4; Regulation (EU) 2022/2347, Article 1(b) | Yes |
Notified body involvement
Reclassification was adopted so that a notified body would examine these products; recital 8 of Regulation (EU) 2022/2347 says so in terms. The notified body route for class IIb is Article 52(4), quality management system assessment under Chapters I and III of Annex IX with assessment of the technical documentation of at least one representative device per generic device group; for class IIa hair removal devices Article 52(6) applies with the same structure per category of devices.
Transitional provisions: 31 December 2028 and the 1 January 2027 agreement
A laser or IPL product that was already lawfully on the market in the Union before 22 June 2023 can stay on the market for a limited time while the notified body assessment runs. For a product without a clinical investigation:
"A product for which the manufacturer does not intend to perform a clinical investigation, but in the conformity assessment of which a notified body has to be involved in accordance with Article 52 of that Regulation, may be placed on the market or put into service until 31 December 2028, provided that the following conditions are met: (a) the product was already lawfully marketed in the Union before 22 June 2023 and continues to comply with the requirements of Union and national law that were applicable to it before 22 June 2023; (b) there are no significant changes in the design and intended purpose of the product."
Source: Commission Implementing Regulation (EU) 2022/2346, Article 2(2), as amended by Regulation (EU) 2023/1194
From 1 January 2027 that period comes with a further condition:
"By way of derogation from the first subparagraph, from 1 January 2027 until 31 December 2028, a product that meets the conditions laid down in that subparagraph may only be placed on the market or put into service, if a written agreement for the performance of the conformity assessment has been signed by the notified body and the manufacturer in accordance with Section 4.3, second subparagraph, of Annex VII to Regulation (EU) 2017/745."
Source: Commission Implementing Regulation (EU) 2022/2346, Article 2(2), as amended by Regulation (EU) 2023/1194
For a product that needs a clinical investigation, Article 2(1) of the same Regulation allows placing on the market until 31 December 2029, with a signed notified body agreement required from 1 January 2028. A product first placed on the market on or after 22 June 2023 has no transitional period and needs the notified body certificate first.
The authorized representative: Article 11
Whether an aesthetic laser or IPL manufacturer needs an EU authorized representative does not depend on the class of the product. It depends on where the manufacturer is established. Article 11(1) is the operative sentence:
"Where the manufacturer of a device is not established in a Member State, the device may only be placed on the Union market if the manufacturer designates a sole authorised representative."
Source: Regulation (EU) 2017/745, Article 11(1)
Article 11(2) requires the mandate to be accepted in writing and to cover at least all devices of the same generic device group. Article 11(3) then lists the minimum tasks. The Regulation, including Article 11, applies to Annex XVI products under Article 1(2), so a cosmetic laser manufacturer in China, Korea, the United States or Israel is in the same position as a manufacturer of a surgical laser.
"(a) verify that the EU declaration of conformity and technical documentation have been drawn up and, where applicable, that an appropriate conformity assessment procedure has been carried out by the manufacturer;"
Source: Regulation (EU) 2017/745, Article 11(3)(a)
"(b) keep available a copy of the technical documentation, the EU declaration of conformity and, if applicable, a copy of the relevant certificate, including any amendments and supplements, issued in accordance with Article 56, at the disposal of competent authorities for the period referred to in Article 10(8);"
Source: Regulation (EU) 2017/745, Article 11(3)(b)
"(g) immediately inform the manufacturer about complaints and reports from healthcare professionals, patients and users about suspected incidents related to a device for which they have been designated;"
Source: Regulation (EU) 2017/745, Article 11(3)(g)
One mandate for the European Union and Türkiye
Medex is established in Türkiye and registered in EUDAMED as an authorized representative under SRN TR-AR-000057550, so an aesthetic laser or IPL manufacturer outside both the EU and Türkiye covers both markets with one mandate. MDCG 2022-16, footnote 1:
"The ’Union market’ refers to the territories of the European Union Member States, and due to the European Economic Area (EEA) is extended to Norway, Lichtenstein and Iceland, and via the Customs Union Agreement to Turkey."
Source: MDCG 2022-16, Guidance on Authorised Representatives, footnote 1
The Commission's Notice to Stakeholders of March 2022 draws the conclusion:
"manufacturers established outside the territory of the EU or Turkey only need to designate one authorised representative, either in the EU or in Turkey, in order to place medical devices on the market in the EU or in Turkey."
Source: European Commission, Notice to Stakeholders: EU-Turkey Customs Union Agreement in the field of medical devices, Section I.2
Placing the product on the Turkish market also requires registration in ÜTS (Ürün Takip Sistemi), Türkiye's product tracking system, a separate service under a separate contract: see ÜTS registration for foreign manufacturers and laser hair removal device ÜTS registration in Türkiye (Turkish).
What Medex does under the mandate
We verify that the EU declaration of conformity and technical documentation for each aesthetic laser or IPL device exist and that the notified body procedure has been carried out, keep copies for the period in Article 10(8), register in EUDAMED and check your Basic UDI-DI records, answer competent authority requests, cooperate on corrective actions and pass complaints and suspected incidents to you without delay. A person responsible for regulatory compliance is available in-house.
A class IIb skin treatment laser falls in the band of €1,200 to 1,600 per year and a class IIa hair removal device in the band of €1,000 to 1,300 per year, fixed for three years from signature. Setup is €0 and a change of representative costs €150; see pricing and EU authorized representative cost. We do not prepare the clinical evaluation regarding safety required by the common specifications. We are not a notified body and we do not find importers or distributors. Offices in Ankara and İstanbul.
The symbol that identifies the representative on your label is explained in our guide to the EC REP meaning. If some devices are still placed on the market under the former directives, see the authorized representative for legacy devices.
Related pages
Other Annex XVI groups: fat reduction and body contouring equipment, dermal fillers and contact lenses. Fibre optics for surgical lasers are on the endoscopes page; all groups are on the medical device categories page. The general guide is EU authorized representative.
Frequently asked questions
Our IPL device is cosmetic only. Does the MDR apply?
Yes. Article 1(2) extends the MDR to the Annex XVI groups from the date of application of their common specifications, and Regulation (EU) 2022/2346 applies from 22 June 2023. Point 5 of Annex XVI names lasers and intense pulsed light equipment.
Is a hair removal laser class IIa or IIb?
Class IIa if it is intended for hair removal only. Article 1(a) of Regulation (EU) 2022/2347 reclassifies equipment intended for skin treatment as class IIb, unless it is intended for hair removal only, in which case it is class IIa.
What counts as skin treatment for the class IIb branch?
Annex VI of Regulation (EU) 2022/2346 covers skin resurfacing, including skin rejuvenation, tattoo removal, including removal of permanent make-up, and other non-medical skin treatments such as pigmented areas and scars. A device claiming any of these is class IIb.
Does a cosmetic laser manufacturer outside the EU need an authorized representative?
Yes. Annex XVI products are regulated as devices, and Article 11(1) requires a manufacturer not established in a Member State to designate a sole authorized representative.
Does one Medex mandate cover the EU and Türkiye?
Yes. Medex is established in Türkiye, and the Commission Notice of March 2022 states that manufacturers outside the EU or Turkey only need to designate one authorized representative, either in the EU or in Turkey.
Sources and further reading
Regulation (EU) 2017/745 on medical devices, consolidated text: eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:02017R0745-20250110
Commission Implementing Regulation (EU) 2022/2347 on the reclassification of groups of certain active products without an intended medical purpose: eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:32022R2347
Commission Implementing Regulation (EU) 2022/2346 laying down common specifications for Annex XVI products, consolidated text: eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:02022R2346-20230622
MDCG 2021-24, Guidance on classification of medical devices: health.ec.europa.eu/medical-devices-sector/new-regulations/guidance-mdcg-endorsed-documents-and-other-guidance_en
MDCG 2022-16, Guidance on Authorised Representatives Regulation (EU) 2017/745 and Regulation (EU) 2017/746: health.ec.europa.eu/medical-devices-sector/new-regulations/guidance-mdcg-endorsed-documents-and-other-guidance_en
European Commission, Notice to Stakeholders: EU-Turkey Customs Union Agreement in the field of medical devices (March 2022): health.ec.europa.eu/system/files/2022-04/md_eu-turkey_customs-union_en.pdf
Request a fixed-price EU authorized representative quote for your aesthetic laser or IPL equipment.
Request a proposal · View pricing · Appoint Medex as your authorized representative
